Maka Hospice, Inc. v. Alex M. Azar, II

CourtDistrict Court, C.D. California
DecidedAugust 19, 2019
Docket2:19-cv-07065
StatusUnknown

This text of Maka Hospice, Inc. v. Alex M. Azar, II (Maka Hospice, Inc. v. Alex M. Azar, II) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Maka Hospice, Inc. v. Alex M. Azar, II, (C.D. Cal. 2019).

Opinion

O 1

2 3 4 5 6 7 United States District Court 8 Central District of California 9 10 MAKA HOSPICE, INC., 11 Case No: 2:19-cv-07065-DDP (AFMx)

12 Plaintiff, ORDER DENYING PLAINTIFF’S 13 v. EX PARTE APPLICATION FOR 14 TEMPORARY RESTRAINING 15 ALEX M. AZAR II, SECRETARY OF ORDER [6]; AND ORDER TO SHOW HEALTH AND HUMAN SERVICES, 16 CAUSE RE: SUBJECT MATTER 17 Defendant. JURISDICTION 18 19 I. INTRODUCTION 20 Plaintiff Maka Hospice, Inc. (“Maka Hospice”) filed its Complaint on August 21 13, 2019, against Defendant Alex M. Azar II, Secretary of Health and Human 22 Services, for various claims resulting from Defendant’s suspension of Maka Hospice’s 23 Medicare payments. (Compl. ¶ 9, ECF No. 1.) On August 14, 2019, Maka Hospice 24 brought an Ex Parte Application for Temporary Restraining Order Compelling 25 Payment of Funds Withheld by Defendant (“Application”). (Appl. 1, ECF No. 6.) 26 For the following reasons, the Court DENIES the Application.1 27

28 1 After carefully considering the papers filed in support of the application, the Court deems the matter appropriate for decision without oral argument. Fed. R. Civ. P. 78; C.D. Cal. L.R. 7-15. 1 II. FACTUAL BACKGROUND 2 Maka Hospice is a licensed and qualified hospice facility providing services to 3 patients diagnosed as terminally ill. (Compl. ¶ 6.) On November 14, 2018, 4 Defendant’s agent, Qlarant Integrity Solutions, LLC (“Qlarant”), conducted a surprise 5 audit of Maka Hospice’s facilities. (Compl. ¶ 9.) Following this audit, “Qlarant 6 concluded that there were ‘credible allegations of fraud’ and . . . imposed a unilateral 7 suspension of Medicare payments due to [Maka Hospice].” (Compl. ¶ 9.) 8 On May 9, 2019, the Centers for Medicare and Medicaid Services (“CMS”) 9 sent Maka Hospice a letter indicating that it was suspending Maka Hospice’s 10 Medicare payments without prior notice because “giving prior notice would place 11 additional Medicare funds at risk and hinder [its] ability to recover any determined 12 overpayment.” (Compl. Ex. 1, at 1.) On May 22, 2019, Maka Hospice through its 13 attorney, sent a rebuttal letter challenging the suspension of Medicare payments. (See 14 Compl. Ex. 2.) 15 Maka Hospice alleged that Defendant has delayed resolution of the case; thus, 16 necessitating this action and Application. (See Appl. 4.) Maka Hospice further 17 alleged that the delays have and will continue to cause it immediate and irreparable 18 harm such as the imminent closure of its business, which would result in serious 19 health risks to its patients. (Appl. 4.) 20 Accordingly, Maka Hospice, through this Ex Parte Application, seeks “to 21 compel Medicare to continue making payment for past and future services for the 22 treatment of patients.” (Appl. 4.) 23 III. SUBJECT MATTER JURISDICTION 24 Before the Court addresses the Application, the Court reviews whether it has 25 subject matter jurisdiction over this case. Maka Hospice alleges that this Court has 26 subject matter jurisdiction pursuant to 42 C.F.R. §§ 405.980 and 405.1132. However, 27 Maka Hospice’s allegations are insufficient. 28 1 CMS can suspend payments to a Medicare provider “in whole or in part,” when 2 it determines “a credible allegation of fraud exists against a provider or supplier.” 42 3 C.F.R. § 405.371(a)(2). When CMS suspends a provider’s payments, it must provide 4 the provider an opportunity to submit a rebuttal statement as to why CMS should end 5 the suspension. 42 C.F.R. §§ 405.373(a)(2), 405.374. This determination is not 6 appealable and “is not an initial determination” within the Medicare Act’s 7 administrative process. 42 C.F.R. § 405.375(c); cf. 42 C.F.R. § 405.924 (listing 8 actions considered initial determinations). 9 After suspending payments, CMS must reevaluate every 180 days whether good 10 cause exists to continue the suspension. 42 C.F.R § 405.371(b)(2)(i). CMS must end 11 the suspension after 18 months, unless the case has been referred to, or is being 12 considered by, the Office of Inspector General for administrative action or the 13 Department of Justice requests that the suspension continue. 42 C.F.R. 14 § 405.371(b)(3). During the suspension period, CMS processes all claims received 15 and determines whether the services provided were proper or if overpayment 16 occurred. See generally 42 C.F.R. 405.372(e). If at the end of the investigation, CMS 17 finds that overpayment to the provider occurred, CMS will use the suspended 18 payments to reduce or eliminate any overpayment, and it will then pay the excess 19 amount to the provider. Id. CMS’s determination of whether an overpayment 20 occurred triggers a multi-step administrative appeals process for a provider to follow 21 if it is dissatisfied with the initial overpayment determination. 42 C.F.R. 22 § 405.904(a)(2). The administrative appeal steps are: (1) a determination of the initial 23 overpayment decision (42 C.F.R. § 405.940 et seq.); (2) a reconsideration by a 24 qualified independent contractor (“QIC”) (42 C.F.R. § 405.960 et seq.); (3) a de novo 25 review and hearing before an Administrative Law Judge (“ALJ”) (42 C.F.R. 26 § 405.1002(b)); and (4) a review and decision by the Medicare Appeals Council 27 (“Council”) (42 C.F.R. § 405.1102(a)). A provider may seek review in a federal 28 1 district court only after receiving a decision from the Council. 42 C.F.R. § 405.1136; 2 see also 42 C.F.R. § 405.1130. 3 Federal courts are vested with jurisdiction over only a final decision of the 4 Department of Health and Human Services. 42 U.S.C. § 405(g), (h); see also 42 5 U.S.C. § 1395ff(b)(1)(a) (making § 405(g) applicable to Medicare); Hironymous v. 6 Bowen, 800 F.2d 888, 894 (9th Cir. 1986) (“The finality condition has been held to 7 include a nonwaivable requirement of presentation of the claim and a waivable 8 requirement of exhaustion of administrative remedies.”).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Maka Hospice, Inc. v. Alex M. Azar, II, Counsel Stack Legal Research, https://law.counselstack.com/opinion/maka-hospice-inc-v-alex-m-azar-ii-cacd-2019.